Race Differences in Patient-Reported Symptoms during Chemotherapy among Women with Early-Stage Hormone Receptor-Positive Breast Cancer.

MLA

Xin Hu, et al. “Race Differences in Patient-Reported Symptoms during Chemotherapy among Women with Early-Stage Hormone Receptor-Positive Breast Cancer.” Cancer Epidemiology, Biomarkers & Prevention, vol. 32, no. 2, Feb. 2023, pp. 167–74. EBSCOhost, https://doi.org/10.1158/1055-9965.EPI-22-0692.

APA

Xin Hu, Kaplan, C. M., Martin, M. Y., Walker, M. S., Stepanski, E., Schwartzberg, L. S., Vidal, G. A., & Graetz, I. (2023). Race Differences in Patient-Reported Symptoms during Chemotherapy among Women with Early-Stage Hormone Receptor-Positive Breast Cancer. Cancer Epidemiology, Biomarkers & Prevention, 32(2), 167–174. https://doi.org/10.1158/1055-9965.EPI-22-0692

Chicago

Xin Hu, Cameron M. Kaplan, Michelle Y. Martin, Mark S. Walker, Edward Stepanski, Lee S. Schwartzberg, Gregory A. Vidal, and Ilana Graetz. 2023. “Race Differences in Patient-Reported Symptoms during Chemotherapy among Women with Early-Stage Hormone Receptor-Positive Breast Cancer.” Cancer Epidemiology, Biomarkers & Prevention 32 (2): 167–74. doi:10.1158/1055-9965.EPI-22-0692.